Search Results for "1"
Search again or select article below to purchase. Single article price: $45. Order 3 or more at one time and receive a 10% discount.
Sort by relevance | Sort by date
Searched for 1. Results 2611 to 2620 of 2621 total matches.
Escitalopram (Lexapro) for Depression
The Medical Letter on Drugs and Therapeutics • Sep 30, 2002 (Issue 1140)
: www.medicalletter.org
Subscriptions (U.S.)
1 year-$59; 2 years-$99; 3 years-$142
$29.50 per year for students ...
Escitalopram (Lexapro - Forest), the active S-enantiomer of racemic citalopram (Celexa - Forest), a selective serotonin reuptake inhibitor (SSRI), was recently approved by the FDA for treatment of depression. The manufacturer plans to stop promoting Celexa in favor of Lexapro; Celexa will continue to be available for patients already taking it.
Indications for an Implantable Cardioverter Defibrillator
The Medical Letter on Drugs and Therapeutics • Nov 25, 2002 (Issue 1144)
Web Site: www.medicalletter.org
Subscriptions (U.S.)
1 year-$59; 2 years-$99; 3 years-$142.
$29.50 ...
There is no longer any doubt that an implantable cardioverter defibrillator (ICD) can reliably terminate most life-threatening ventricular tachyarrhythmias. The remaining question is who should get one. Guidelines prepared by an American College of Cardiology/American Heart Association task force have recently been published (G Gregoratos et al, Circulation 2002; 106:2145).
In Brief: Tamoxifen and SSRI Interactions
The Medical Letter on Drugs and Therapeutics • Jun 15, 2009 (Issue 1314)
Subscriptions (US):
1 year - $98; 2 years - $167;
3 years - $235. $49.00 per year for
students, interns ...
Use of a selective serotonin reuptake inhibitor (SSRI) is common in women taking tamoxifen (Nolvadex, and others) for breast cancer, both to treat depression and to decrease hot flashes. However, tamoxifen must be metabolized by CYP2D6 to become pharmacologically fully active (MJ Higgins et al. J Natl Compr Canc Netw 2009; 7:203), and the SSRIs fluoxetine (Prozac, and others) and paroxetine (Paxil, and others) are strong inhibitors of CYP2D6. Sertraline (Zoloft, and others) inhibits CYP2D6 to a lesser extent. Citalopram (Celexa, and others) and escitalopram (Lexapro), the 2 other SSRIs...
In Brief: Only The Name Remains The Same
The Medical Letter on Drugs and Therapeutics • Jun 28, 2010 (Issue 1341)
to:
permissions@medicalletter.org
Subscriptions (US):
1 year - $98; 2 years - $167;
3 years - $235. $49.00 ...
A Medical Letter subscriber was surprised to discover that a new Citracal product contained not only calcium citrate, but also calcium carbonate. Citracal Plus Bone Density Builder actually contains more calcium carbonate per tablet than calcium citrate (240 mg vs. 60 mg). Another Citracal product, Citracal Plus Heart Health, also contains more calcium carbonate than calcium citrate. Many clinicians prefer calcium citrate because it can be taken with or without food, while calcium carbonate must be taken with food for optimal absorption. Other familiar over-the-counter (OTC) names also contain...
Generic drugs
The Medical Letter on Drugs and Therapeutics • Oct 14, 2002 (Issue 1141)
Phone: 914-235-0500 Fax: 914-632-1733
Web Site: www.medicalletter.org
Subscriptions (U.S.)
1 year-$59 ...
When patents expire on brand-name drugs and generic formulations become available, patients and managed care organizations may express a preference for the lower-cost generics. Are they equivalent to the brand-name product?
Methamphetamine Abuse
The Medical Letter on Drugs and Therapeutics • Aug 02, 2004 (Issue 1188)
to disclose any potential conflict of interest.
Subscriptions (U.S.)
1 year-$63; 2 years-$107; 3 years-$151 ...
Methamphetamine, a highly addictive synthetic sympathomimetic, has again become important as a drug of abuse in the US. Its resurgence has been associated with unsafe sexual practices that have resulted in an increase in HIV transmission, particularly among men who have sex with men (SJ Semple et al, J Subst Abuse Treat 2002; 22:149; A Urbina and K Jones, Clin Infect Dis 2004; 38:890).
Alefacept (Amevive) For Treatment of Psoriasis
The Medical Letter on Drugs and Therapeutics • Apr 14, 2003 (Issue 1154)
: www.medicalletter.org
Subscriptions (U.S.)
1 year-$59; 2 years-$99; 3 years-$142.
$29.50 per year for students ...
Alefacept (a le' fa sept; Amevive - Biogen) has been approved by the FDA for parenteral treatment of adults with moderate to severe chronic plaque psoriasis.
Catheter Ablation for Atrial Fibrillation
The Medical Letter on Drugs and Therapeutics • Jul 19, 2004 (Issue 1187)
to disclose any potential conflict of interest.
Subscriptions (U.S.)
1 year-$63; 2 years-$107; 3 years-$151 ...
Advertisements are appearing in medical journals for continuing medical education courses on catheter ablation of atrial fibrillation. Is a cure at hand for this common disorder?
Problems With Dietary Supplements
The Medical Letter on Drugs and Therapeutics • Sep 30, 2002 (Issue 1140)
: www.medicalletter.org
Subscriptions (U.S.)
1 year-$59; 2 years-$99; 3 years-$142
$29.50 per year for students ...
Millions of people now take herbal products and other "dietary supplements." The Physicians' Desk Reference has published a PDR for Herbal Medicines listing their ingredients and indications, and the Drug Topics Red Book lists their prices.
Prevention and Treatment of Heat Injury
The Medical Letter on Drugs and Therapeutics • Jul 21, 2003 (Issue 1161)
Web Site: www.medicalletter.org
Subscriptions (U.S.)
1 year-$59; 2 years-$99; 3 years-$142.
$29.50 ...
Summer heat waves cause thousands of cases of heat-related illness in the US each year and hundreds of heat-related deaths, especially among the elderly. This review describes the contributing factors, clinical signs, and ways to prevent and treat heat injury.